ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,335Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 134

$470K Total Retail Price of All Prescriptions

Rank: 42 out of 134

316 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 316 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 316 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 7,668 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
LEVOTHYROXINE SODIUM 548 494 1 1
SIMVASTATIN 371 357 2 2
AMLODIPINE BESYLATE 318 315 3 6
OMEPRAZOLE 292 239 4 3
FUROSEMIDE 254 220 5 7
METFORMIN HCL 203 203 6 9
LISINOPRIL 193 174 7 4
RAMIPRIL 184 163 8 73
METOPROLOL SUCCINATE 159 159 9 16
ZETIA 158 146 10 95
LOSARTAN POTASSIUM 157 156 11 11
CARVEDILOL 152 148 12 27
HYDROCODONE-ACETAMINOPHEN 149 138 S3 13 5
HYDROCHLOROTHIAZIDE 128 112 14 13
ATORVASTATIN CALCIUM 125 112 15 18
WARFARIN SODIUM 122 119 16 8
DIOVAN 118 105 17 55
PRAVASTATIN SODIUM 110 103 18 20
METOPROLOL TARTRATE 108 108 19 17
CITALOPRAM HBR 95 95 20 14
LANTUS 92 92 21 32
POTASSIUM CHLORIDE 89 71 22 10
HYDRALAZINE HCL 88 86 23 151
GEMFIBROZIL 81 81 24 87
ALENDRONATE SODIUM 81 68 24 21
ACTOS 79 51 26 81
TRAMADOL HCL 76 72 27 22
SPIRONOLACTONE 71 71 28 29
CRESTOR 70 66 29 39
DONEPEZIL HCL 70 70 29 30
METOCLOPRAMIDE HCL 68 53 31 98
ZOLPIDEM TARTRATE 68 67 31 15
SYNTHROID 67 58 33 56
PROAIR HFA 64 45 34 49
INDAPAMIDE 64 53 34 170
ALLOPURINOL 61 61 36 25
GABAPENTIN 59 45 37 12
SERTRALINE HCL 58 56 38 24
PANTOPRAZOLE SODIUM 57 57 39 57
FLUOXETINE HCL 57 49 39 42
DIGOXIN 55 55 41 31
LOSARTAN-HYDROCHLOROTHIAZIDE 54 52 42 50
BYSTOLIC 54 54 42 126
OXYBUTYNIN CHLORIDE ER 52 48 44 106
CLOPIDOGREL 51 50 45 52
FENTANYL 51 50 S2 45 41
VENLAFAXINE HCL ER 51 48 45 61
PERINDOPRIL ERBUMINE 50 50 48 243
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.